A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
One of the few treatments the Food and Drug Administration has approved for amyotrophic lateral sclerosis has failed a large clinical trial, and its manufacturer said Friday that it was…










